Melodiol Global Health Signs AU$12 Million Letter of Intent for Sale of Canadian Assets
Melodiol Global's Mernova Unit Launches More Products; Shares Jump 50%
Melodiol Global's Revenue Surges 79% in Q1
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces
Melodial's Unit Logs AU$1 Million Revenues in January
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October
Melodiol Global Health Achieves 80% Remission Rate From Phase Two Hallucinogenic Trial
Melodial's Canadian Arm Mernova Logs Record Sales in Q3
Melodiol Logs Strong Start to Q3 With AU$1.6 Million in Revenue and Confirmed Purchase Orders
Melodiol Global Health Triples Q2 Net Sales
No Data
No Data